Should I buy Ovintiv (OVV) stock or is it too late?
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
Firm-by-firm track record on Ovintiv
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Morgan Stanley | 58 % | +36.8 % | 12 | $65 +0% |
| UBS | 46 % | +33.1 % | 13 | $74 +14% |
| Wells Fargo | 50 % | +26.5 % | 6 | $78 +20% |
| JP Morgan | 57 % | +21.6 % | 7 | $47 -28% |
| Truist Securities | 36 % | +9.9 % | 11 | $73 +12% |
| Barclays | 36 % | +5.0 % | 14 | $75 +15% |
| Citigroup | 29 % | -0.6 % | 7 | $66 +1% |
| RBC Capital | 20 % | -1.5 % | 5 | $85 +30% |
✅ Reasons to believe
- 79% of analysts rate it a buy (Buy consensus, 14 ratings) — a sign of market conviction.
- Pays a dividend (2.3% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- Even the most reliable firm on OVV, Goldman Sachs (75% hit rate, 4 scored calls), only targets $62 (call made on March 11, 2026, maturing on March 11, 2027) (-5%) in its most recent call. The stock may already have run past its target.
- The consensus is not unanimous: of 14 ratings, 3 are neutral.
- Limited upside: the median target is only +6% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
The analyst consensus on OVV
Median target $69 (+6%) · 14 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Ovintiv now?
We won't decide for you. The facts: 79% of analysts rate it a buy, median target $69 (+6%), and Goldman Sachs (most reliable on OVV, 75%) targets $62. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Ovintiv?
Not according to analysts: the median target ($69) is still +6% above the current price ($65) (most reliable on OVV: Goldman Sachs, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Ovintiv still worth investing in?
It depends on the gap between the price ($65) and its estimated value: analysts target $69 on median (+6%), with 79% buys (most reliable on OVV: Goldman Sachs, 75%). Cross-check with their real reliability on OVV and the cautions above. Information, not advice.
What's the main risk in buying OVV?
Even the most reliable firm on OVV, Goldman Sachs (75% hit rate, 4 scored calls), only targets $62 (call made on March 11, 2026, maturing on March 11, 2027) (-5%) in its most recent call. The stock may already have run past its target.
→ Go deeper: the full Ovintiv profile (consensus, analyst reliability, price target, performance).